YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Profile Avatar - Palmy Investing

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also man…
Drug Manufacturers - Specialty & Generic
CN, Yichang [HQ]
1558.HK/Financials
Wall Street · Earnings · Institutional Sentiment

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. can't present any analysts estimates at the moment detail analysis.
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Overall Consensus
Grading Consensus
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. can't present the grade consensus distribution right now.
Price Target Consensus
Price Then
$n/a
Price Target
$n/a
Price Now
$9.60